From the Journals
The SS/LS ratio is significantly higher in patients with HCV than in those with alcohol-related liver disease (ALD).
No prior authorization will be necessary for a specific combination of direct-acting antiviral agents starting July 15.
Diabetes incidence was lower in hepatitis C patients treated with DAAs than in untreated patients.
Mannose-binding lectin and ficolin-2 are potential biomarkers for the development of liver cancer in chronic HCV infection.
Large, prospective study showed direct-acting antivirals reduced mortality and cancer risk in chronic HCV-infected patients.
SAN FRANCISCO –